版本:
中国

BRIEF-U.S. FDA says expanded approved use of Subcutaneous Actemra to treat adults with Giant Cell Arteritis

May 22 U.S. FDA:

* U.S. FDA says expanded the approved use of Subcutaneous Actemra (Tocilizumab) to treat adults with Giant Cell Arteritis

* U.S. FDA says the FDA granted the supplemental approval of Actemra to Hoffman La Roche Inc Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐